Embolotherapy Market to Grow at a CAGR of 8.8% from 2025 to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The Embolotherapy Market Size During 2025–2029?

The embolotherapy market has shown robust expansion in recent years. It is projected to expand from $4.44 billion in 2024 to $4.84 billion in 2025, with a compound annual growth rate (CAGR) of 9.0%. This historical expansion is attributable to several factors, including a rising demand for embolotherapy in managing various conditions, an increasing occurrence of cancer, a higher incidence of peripheral vascular diseases, growing healthcare expenditure, and augmented investment in research.

The embolotherapy market is projected to experience robust expansion over the coming years, reaching a valuation of $6.77 billion by 2029, driven by an 8.8% compound annual growth rate (CAGR). This anticipated growth is primarily fueled by factors such as an uptick in disposable income, the escalating occurrence of chronic illnesses, broader acceptance in reproductive health applications, a greater volume of chemoembolization procedures, and the increasing cases of liver cancer. Key developments expected during this period encompass advancements like cutting-edge technologies, the introduction of digital and analog devices, insertable cardiac monitors, refined embolotherapy techniques, and an emphasis on strategic collaborations.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21181&type=smp

Which Drivers Are Impacting The Embolotherapy Market?

The increasing inclination towards minimally invasive procedures is anticipated to fuel the expansion of the embolotherapy market in the future. These procedures are defined as cosmetic treatments requiring minimal to no surgical involvement, generally characterized by short recovery periods and reduced associated risks. The growing demand for such procedures stems from benefits like quicker recovery times, diminished pain, smaller scarring, decreased chances of complications, and ongoing technological advancements. Embolotherapy complements minimally invasive techniques by precisely obstructing blood flow to specific vessels, thereby curbing bleeding, addressing tumors, and managing vascular irregularities with enhanced accuracy and fewer adverse effects. For example, data from September 2023, published by the American Society of Plastic Surgeons, a US-based non-profit body, indicated a 7% increase in cosmetic minimally invasive procedures in 2023, escalating to 25,442,640 from 23,672,269 in 2022. Consequently, the heightened preference for minimally invasive procedures is acting as a catalyst for the expansion of the embolotherapy market.

What Are The Segment Types Shaping The Embolotherapy Market?

The embolotherapymarket covered in this report is segmented –

1) By Product: Embolization Coil; Embolic Agents; Detachable Balloons; Embolic Plug Systems; Support Devices

2) By Application: Oncology; Peripheral Vascular Diseases; Urology and Nephrology; Neurology; Gastrointestinal (GIT) Disorders

3) By Procedure: Transcatheter Arterial Embolization (TAE); Transcatheter Arterial Radioembolization (TARE) Or Selective Internal Radiation Therapy (SIRT); Transarterial Chemoembolization (TACE)

4) By End User: Ambulatory Surgical Centre; Hospitals And Clinics; Other End Users

Subsegments:

1) By Embolization Coil: Bare Coils; Coated Coils; Micro Coils

2) By Embolic Agents: Liquid Embolic Agents; Particulate Embolic Agents; Gelatin Sponge; Polyvinyl Alcohol (PVA) Particles

3) By Detachable Balloons: Single-Use Balloons; Multi-Use Balloons

4) By Embolic Plug Systems: Plug Kits; Distal Occlusion Systems

5) By Support Devices: Guidewires; Catheters; Sheath Introducers

What Long-Term Trends Will Shape The Future Growth Of The Embolotherapy Industry?

Major companies engaged in the embolotherapy market are prioritizing the development of novel products, including absorbable embolic systems, to enhance patient outcomes and expand available treatment options. Absorbable embolic systems consist of bioresorbable materials employed in embolization procedures to impede blood flow to targeted tissues, such as tumors or aneurysms, gradually disintegrating within the body over time. For example, in January 2025, Instylla Inc., a US-based medical equipment manufacturing company, obtained U.S. Food and Drug Administration (FDA) 510(k) clearance for its Tembo embolic system, which is a bioresorbable embolization agent made of irregularly shaped, dry-gelatin particles sized between 85 and 255 µm. This system is engineered to embolize hypervascular tumors and occlude blood vessels in the peripheral vasculature. According to Instylla, Tembo offers advantages such as ease of preparation, high visibility, and the ability to densely pack treated vessels, potentially improving upon existing permanent embolic solutions.

Who Are The Major Companies Operating In The Embolotherapy Market?

Major companies operating in the embolotherapy market are Boston Scientific Corporation, Terumo Medical Corporation , Medtronic PLC, Johnson And Johnson, Stryker Corporation, Sirtex Medical, Abbott Laboratories, Acandis GmbH, Balt Group LLC, Penumbra Inc, Merit Medical Systems, Kaneka Corporation, Meril Life Sciences Pvt. Ltd., Shape Memory Medical Inc, Guerbet, IMBiotechnologies Ltd, Cardiva , Rapid Medical, Emboline Inc, Microport Scientific, Inari Medical, Instylla Inc, Embolx Inc, GE Healthcare, Lepu Medical Technology Co Ltd, WEGO HEALTHCARE (SHENZHEN) CO., LTD, Achieva Medical Inc, Varian Medical Syatems Inc

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/embolotherapy-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The Embolotherapy Market?

North America was the largest region in the embolotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the embolotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Embolotherapy Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21181&type=smp

Browse Through More Reports Similar to the Global Embolotherapy Market 2025, By The Business Research Company

Warship And Naval Vessels Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/warship-and-naval-vessels-global-market-report

Fiber Reinforced Plastic Vessels Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/fiber-reinforced-plastic-vessels-global-market-report

Offshore Support Vessel Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/offshore-support-vessel-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795